Journal List > Ann Dermatol > v.32(1) > 1141669

Lee, Park, Yoon, and Cho: Eccrine Syringofibroadenoma Associated with Bowen's Disease: A Case Report and Review of the Literature

Abstract

Eccrine syringofibroadenoma (ESFA) is a rare, benign adnexal neoplasm which usually manifests as a solitary nodule on the extremities of elderly patients. Few case reports have described an association between ESFA and carcinomas including squamous cell carcinoma, porocarcinoma, and basal cell carcinoma. A 66-year-old male presented with a pruritic, erythematous brownish solitary plaque with crusted and verrucous surface on the extensor side of the right thigh. The lesion developed 6 to 7 years ago, and had been growing slowly. Biopsy revealed anastomosing epithelial strands which were composed of 2 areas: the upper area consisting of dysplastic cells with prominent nucleoli and abundant mitoses, and the lower area consisting of oval and round cells, and occasionally small luminal ducts. Dysplastic cells comprised almost the entire epidermis but did not invade into the dermis. Benign syringofibroadenomatous lesion surrounded the dysplastic cells in the lowermost portion of the epidermis. Although it is still unclear whether ESFA undergoes malignant transformation or it is a reactive change to carcinoma, complete excision should be performed to prevent malignant transformation with unknown risk.

INTRODUCTION

Eccrine syringofibroadenoma (ESFA) is a rare, benign adnexal neoplasm which shows eccrine differentiation12. Few case reports have described an association between ESFA and carcinomas including squamous cell carcinoma (SCC), porocarcinoma, and basal cell carcinoma (BCC). It is still unclear whether ESFA undergoes malignant transformation or if it is a reactive change secondary to carcinoma3. Here, we describe a rare case of ESFA associated with Bowen's disease (SCC in situ) on the thigh of a 66-year-old male and review the published 17 cases of ESFA associated with carcinoma. We received the consent from patient about publishing all photographic materials.

CASE REPORT

A 66-year-old male presented with a pruritic, 3×2 cmsized, erythematous brownish solitary plaque with crusted and verrucous surface on the extensor surface of the right thigh (Fig. 1). The lesion developed 6 to 7 years ago, and had been growing slowly. There was no palpable inguinal lymph node enlargement, and the patient had been otherwise healthy. Biopsy revealed epithelial strands extending down to the dermis, forming anastomoses (Fig. 2A). Epithelial strands were composed of 2 areas: the upper area consisting of dysplastic cells with prominent nucleoli and abundant mitoses, and the lower area consisting of oval and round cells, and occasionally small luminal ducts (Fig. 2A~C). Dysplastic cells comprised almost the entire epidermis but did not invade into the dermis (Fig. 2A). There was a sharp contrast and demarcation between the upper dysplastic lesion and the benign adenomatous lesion immediately surrounding the dysplastic keratinocytes in the lowermost portion of the epidermis (Fig. 2A). In immunohistochemical stains, epithelial membrane antigen (EMA) was positive in the dysplastic cells and weakly positive in the ductal structures in the adenomatous lower portion (Fig. 2D). p63 was more intensely positive in the dysplastic cells than in the adenomatous cells (Fig. 2E). Carcinoembryonic antigen (CEA) stain was weakly positive in the ductal structures in the adenomatous lower portion (Fig. 2F). The lesion was diagnosed as a reactive ESFA associated with Bowen's disease and was completely excised with free margins of the tumor. Histopathology of excised tissues was also consistent with reactive ESFA associated with Bowen's disease (Fig. 3).

DISCUSSION

Although ESFA most often presents as a slowly growing, solitary, flesh- or reddish-colored nodule or plaque on the extremities of elderly patients, it has various clinical appearance ranging from a solitary erythematous scaly patch to multiple verrucous papules, nodules, and plaques12. The distribution other than extremities includes face, trunk and rarely nails. ESFA is classified into 5 subtypes according to the clinical presentation: (1) solitary ESFA; (2) multiple ESFA with ectodermal dysplasia; (3) multiple ESFA without cutaneous findings; (4) unilateral linear ESFA; and (5) reactive ESFA. However, its histopathologic findings are peculiar and common to all subtypes. Typically, anastomosing strands and cords of monomorphous epithelial cells proliferate and are surrounded by abundant fibrous stroma. Occasionally small luminal eccrine ducts can be found within these cords24.
Reactive ESFA, first described in 1997 by French5 is a rare ESFA subtype associated with various inflammatory dermatoses or neoplasms. Venous stasis and ulceration is the most common dermatoses reported to be associated with ESFA6, and others include trauma, hyperkeratotic eczema, burn scars, lichen planus, elephantiasis, bullous pemphigoid, eccrine poroma, and hidroacanthoma simplex46. Even among the rare cases of reactive ESFA, ESFA associated with malignant neoplasm is extremely rare and there have been only 18 cases including the present case in the literature to date (Table 1)34678910111213141516. Of the 18 cases, SCC was the most commonly associated carcinoma, which was followed by SCC with porocarcinoma, porocarcinoma, BCC and Bowen's disease (SCC in situ). Metastasis or recurrence after excision has not been reported. All but 2 cases occurred at the age older than 65 years; exceptional 1 case (case 1) occurred in a male's heel with repeated minor trauma, and the other 1 case (case 12) occurred in a female who had a history of numerous actinic keratoses. Dorsum of feet or hands (including fingers) was the most common site, and all 3 cases which occurred on the soles involved the heel area. Extremities were also involved with its extensor surface. The lesion duration showed a wide distribution ranging from 6 weeks to several decades. In most cases, lesions had been growing slowly and recently became painful or bled. Clinical appearance varied considerably ranging from palmoplantar keratoderma (case 2) to an exophytic mass approximately 10 cm in diameter (case 3). Histopathologic features were also variable. Five cases showed the histology of carcinoma with some benign ESFA foci, and conversely, 3 cases showed the histology of benign ESFA with some carcinomatous foci. In the other 10 cases, carcinomatous area and benign ESFA area were abutting contiguously; 1 case (case 3) showed SCC surrounded by ESFA, another 1 case (case 14) showed SCC alternating with ESFA, and other 2 cases (cases 8 and 9) showed mixed features of ESFA, SCC, and porocarcinoma. While there has been an attempt to distinguish carcinomatous area from benign ESFA with immunohistochemical stains, the results were inconsistent. CEA stains ductal structures regardless of whether it is benign or carcinomatous. Notwithstanding EMA, MNF116, p16, and p63 tend to stain carcinomatous area more strongly; however, they can stain benign ESFA area as well. It is still controversial whether ESFA precedes carcinoma and undergoes malignant transformation or if it is a reactive change secondary to carcinoma3. Whereas SCC occurs most frequently on the head and neck and the upper extremity, most of cases occurred on the lower extremity, especially dorsum of the foot, extensor of the leg, or the heel, where the sites were prone to trauma. These findings implicate that venous insufficiency7 or repeated minor trauma2 might be associated with ESFA. No cases of reactive ESFA associated with carcinoma occurred in the head and neck region, the most common site of SCC. Overall, it can be postulated that SCC emerges from ESFA or occurs together with ESFA due to repeated minor trauma. Cases with duration of several decades also support the claim that ESFA precedes carcinoma. Some authors even proposed the term of ‘syringofibrocarcinoma’ to describe carcinoma associated with ESFA in this regard8. In contrast, the hypothesis that ESFA is a secondary change to SCC seems reasonable with respect to cases of ESFA associated with numerous inflammatory or benign neoplastic dermatoses other than carcinoma.
Histopathologically, ESFA is similar to fibroepithelioma of Pinkus, poroma or porocarcinoma, hidroacanthoma simplex or malignant hidracanthoma simplex, and SCC with ductal differentiation. However, in fibroepithelioma of Pinkus, epithelial strands are composed of basaloid cells with stromal retraction, ductal structures within the strands are rare, and scattered mast cells are usually observed9. Poroma shows epithelial strands which are similar to ESFA, but they rarely form anastomoses, and cystic and ductal structures are usually distinctly stained with EMA and CEA917. Porocarcinoma shows marked cytologic atypia and numerous mitotic figures9. An intraepidermal form of poroma and porocarcinoma is called hidroacanthoma simplex and malignant hidroacanthoma simplex, respectively. Although glandular proliferation is rarely observed in SCC, glandular components are typically negative for CEA, and prominent keratinization, keratin pearl and cytologic atypia are typically present in SCC in contrast to ESFA18.
The treatment of choice is complete surgical excision since it is impossible to exclude malignant transformation of ESFA12. When complete excision is difficult due to large involvement area or poor patient condition for surgery, close observation may be an alternative to early excision2. An ESFA lesion that increases in size faster than the initial tumor, becomes painful or bleeds, or forms ulcer or crust is more likely to be associated with malignancy.
This report describes a rare case of ESFA associated with Bowen's diseases with literature review. ESFA associated with carcinoma usually presents with a solitary nodule on the lower extremity of the elderly, usually older than 60 years of age. Although it is uncertain whether ESFA precedes carcinoma or emerges from carcinoma, complete excision should be preferred and potential adjacent malignancy should be meticulously checked for when ESFA is diagnosed.

Figures and Tables

Fig. 1

Pruritic solitary mass on the extensor surface of the right thigh. A 3×2 cm sized, well-circumscribed, erythematous brownish plaque with verrucous and partially crusted surface.

ad-32-57-g001
Fig. 2

Histopathology of the solitary mass. (A) Anastomosing epithelial strands extended down to the dermis and were composed of 2 different areas, i.e., dysplastic cells comprising almost the entire epidermis but not invading into the dermis and benign adenomatous lesion immediately surrounding the dysplastic keratinocytes in the lowermost portion of the epidermis (hematoxylin and eosin [H&E], ×40). (B) Epithelial strands were surrounded by mucinous fibrous stroma, and small luminal ducts were embedded within the strands (H&E, ×100). (C) Dysplastic area was composed of atypical cells with prominent nucleoli and abundant mitoses. Adjacent benign adenomatous portion was composed of oval and round cells (H&E, ×200). (D) Epithelial membrane antigen (EMA) was positive in the cytoplasm of dysplastic cells and weakly positive in the ductal structures in the adenomatous lesion (arrowheads) (EMA, ×40). (E) A p63 was positive in the nucleus of dysplastic cells and weakly positive in the adenoma lesion (p63, ×40). (F) Carcinoembryonic antigen (CEA) stain was weakly positive in the ductal structures in the adenoma lesion (arrowhead and inset on the right upper corner) (CEA, ×40).

ad-32-57-g002
Fig. 3

Histopathology of excised tissues. (A) Epithelial strands formed anastomoses and ductal structures were observed within the epithelial strands extending down into the dermis (hematoxylin and eosin [H&E], ×40). (B, C) Immediately above and adjacent to the syringofibroadenoma lesion, almost the entire epidermis displayed dysplasia with atypical keratinocytes and numerous mitotic figures (H&E, ×100).

ad-32-57-g003
Table 1

Reported cases of eccrine syringofibroadenoma associated with malignant neoplasms

ad-32-57-i001

M: male, F: female, ESFA: eccrine syringofibroadenoma, SCC: squamous cell carcinoma, -: not available, CEA: carcinoembryonic antigen, EMA: epithelial membrane antigen, MNF116: marker which stains keratins 5, 6, 8, 17, and probably 19, BCC: basal cell carcinoma, CAM5.2: marker that detects keratins 8 and 10, AE1: marker that detects keratins 10, 14~16, and 19, AE3: marker that detects keratins 1~8, CK, cytokeratin.

Notes

CONFLICTS OF INTEREST The authors have nothing to disclose.

References

1. Bottino CB, Guimarães TF, Gomes FR, D'Acri AM, Lima RB, Martins CJ. Solitary eccrine syringofibroadenoma--case report. An Bras Dermatol. 2015; 90:3 Suppl 1. 235–238.
pmid pmc
2. Cho E, Lee JD, Cho SH. A case of reactive eccrine syringofibroadenoma. Ann Dermatol. 2011; 23:70–72.
crossref pmid pmc
3. Fernandez-Flores A, Suarez-Penaranda JM, Halec G, Michael KM, Schmitt M. Study of squamous cell carcinoma associated with syringofibroadenoma for 105 types of human papillomavirus and for all currently known types of polyomaviruses. Appl Immunohistochem Mol Morphol. 2014; 22:e41–e44.
crossref
4. Duffy KL, Bowen AR, Tristani-Firouzi P, Florell SR, Hadley ML. Eccrine syringofibroadenoma-like change adjacent to a squamous cell carcinoma: potential histologic pitfall in Mohs micrographic surgery. Dermatol Surg. 2009; 35:519–522.
crossref pmid
5. French LE. Reactive eccrine syringofibroadenoma: an emerging subtype. Dermatology. 1997; 195:309–310.
crossref pmid
6. Hays JP, Malone CH, Goodwin BP, Wagner RF Jr. Reactive Eccrine syringofibroadenoma associated with basal cell carcinoma: a histologic mimicker of fibroepithelioma of pinkus. Dermatol Surg. 2018; 44:738–740.
crossref pmid
7. Kacerovska D, Nemcova J, Michal M, Kazakov DV. Eccrine syringofibroadenoma associated with well-differentiated squamous cell carcinoma. Am J Dermatopathol. 2008; 30:572–574.
crossref pmid
8. González-Serva A, Pró-Rísquez MA, Oliver M, Caruso MG. Syringofibrocarcinoma versus squamous cell carcinoma involving syringofibroadenoma: is there a malignant counterpart of Mascaro's syringofibroadenoma? Am J Dermatopathol. 1997; 19:58–65.
crossref pmid
9. Schadt CR, Boyd AS. Eccrine syringofibroadenoma with coexistent squamous cell carcinoma. J Cutan Pathol. 2007; 34 Suppl 1:71–74.
crossref pmid
10. D'Amato MS, Patterson RH, Guccion JG, White JC, Krasnow SH. Porocarcinoma of the heel. A case report with unusual histologic features. Cancer. 1996; 78:751–757.
pmid
11. Starink TM. Eccrine syringofibroadenoma: multiple lesions representing a new cutaneous marker of the Schöpf syndrome, and solitary nonhereditary tumors. J Am Acad Dermatol. 1997; 36:569–576.
crossref pmid
12. Lele SM, Gloster ES, Heilman ER, Chen PC, Chen CK, Anzil AP, et al. Eccrine syringofibroadenoma surrounding a squamous cell carcinoma: a case report. J Cutan Pathol. 1997; 24:193–196.
crossref pmid
13. Katane M, Akiyama M, Ohnishi T, Watanabe S, Matsuo I. Carcinomatous transformation of eccrine syringofibroadenoma. J Cutan Pathol. 2003; 30:211–214.
crossref pmid
14. Bjarke T, Ternesten-Bratel A, Hedblad M, Rausing A. Carcinoma and eccrine syringofibroadenoma: a report of five cases. J Cutan Pathol. 2003; 30:382–392.
crossref pmid
15. Cho HS, Kim WH, Kim CW, Kim KH, Kim KJ. A case of eccrine syringofibroadenoma associated with squamous cell carcinoma. Korean J Dermatol. 2005; 43:1635–1638.
16. Watanabe R, Mikami M, Kitami A, Akiyama M, Hirohiko S, Iijima M, et al. Eccrine porocarcinoma accompanied by eccrine syringofibroadenoma-like histology. Skin Cancer. 2007; 22:62–67.
crossref
17. Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006; 19 Suppl 2:S93–S126.
crossref
18. Calonje E, Lazar A, Mckee PH. McKee's pathology of the skin: with clinical correlations. 4th ed. Edinburgh: Elsevier/Saunders;2012.
TOOLS
ORCID iDs

Ji Su Lee
https://orcid.org/0000-0003-0207-2107

Hyunsun Park
https://orcid.org/0000-0003-1338-654X

Hyun-Sun Yoon
https://orcid.org/0000-0003-1401-2670

Soyun Cho
https://orcid.org/0000-0003-2468-485X

Similar articles